新型SYK变异导致增强SYK自酸化和PI3K激活在抗体缺乏的患者中
Emily S J Edwards1,2,3, Josh Chatelier4,5, Gregory I Snell6
1Allergy and Clinical Immunology Laboratory, Department of Immunology, School of Translational Medicine, Monash University, 89 Commercial Rd, Melbourne, VIC, 3004, Australia. emily.edwards@monash.edu.
Journal of clinical immunology
|October 20, 2025
概括
一种新型SYK基因变异导致患有主要抗体缺乏症的患者患有低血糖球蛋白血症和自身炎症性疾病. -S6的流细胞计有助于诊断B细胞信号异常在先天性免疫错误.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 免疫的先天性错误 (IEI) 影响B细胞受体信号传递,往往导致主要抗体缺乏 (PAD).
- 已发现四种SYK基因变异与低血糖球蛋白血症,多器官炎症和淋巴瘤有关.
研究的目的:
- 为了确定PAD的遗传和功能原因,在一个43岁的女性患有低血糖球蛋白,先天性心脏病和肺高血压.
- 研究SYK信号在B细胞功能和相关疾病中的作用.
主要方法:
- 整体外体和桑格测序被用来分析患者的基因组DNA.
- 流细胞计评估了B细胞和T细胞子集以及化SYK,S6和p38水平.
- 一个临床前细胞模型表达了已识别的SYK变体,以研究其功能影响.
主要成果:
- 在蛋白质激酶域中发现了一种新型异构错误SYK变体 (p.R590Q).
- 患者的记忆B细胞数量减少,但总B细胞和T细胞数量正常.
- 患者B细胞显示SYK自酸化增强和-S6和-p38水平增加,与功能获取变异一致.
结论:
- 一种新的功能获取SYK变体是患者的低血糖球蛋白血症和非典型的自身炎症性疾病的基础.
- 淋巴细胞中光-S6的流细胞计查可以帮助诊断IEI患者的B细胞信号缺陷.
更多相关视频
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
2.7K
08:38Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
Published on: October 4, 2018
21.8K
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
01:20The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K